Bruker BRKR
NASDAQ BRKR
$54.46 -3.91 (-6.71%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bruker (BRKR) Other Non-Current Liabilities (2010 - 2026)

Bruker's (BRKR) quarterly Other Non-Current Liabilities came in at $597.7 million in Q2 2026, down 19.88% on a YoY basis from $746.0 million in Q2 2025, and down 2.0% quarter-over-quarter from $609.9 million in Q1 2026.

Analysis

Bruker (BRKR) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

Bruker (BRKR) has reported Other Non-Current Liabilities for 17 consecutive years, with $597.7 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Non-Current Liabilities fell 19.88% year-over-year to $597.7 million; the trailing twelve-month figure through Jun 2026 stood at $597.7 million (down 19.88% YoY), and the FY2025 full-year result was $599.4 million, up 92.73% from the prior year.
  • Other Non-Current Liabilities declined to $597.7 million in Q2 2026 per BRKR's latest filing, from $609.9 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $746.0 million in Q2 2025 and bottomed at $120.8 million in Q4 2022.
  • Historically, Other Non-Current Liabilities has averaged $420.1 million across 5 years, with a median of $404.6 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities sank 57.86% in 2024, then soared 318.4% in 2025.
  • Over 5 years, Other Non-Current Liabilities stood at $120.8 million in 2022, then jumped by 98.84% to $240.2 million in 2023, then rose by 29.48% to $311.0 million in 2024, then jumped by 92.73% to $599.4 million in 2025, then declined by 0.28% to $597.7 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $597.7 million, $609.9 million, and $599.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 225.48 Bn 221.41 Bn 8.34 Bn
2 Danaher 144.42 Bn 140.08 Bn 3.61 Bn
3 Agilent Technologies 40.86 Bn 39.11 Bn 1.04 Bn
4 Illumina 30.97 Bn 29.80 Bn 770.00 Mn
5 Revvity 13.85 Bn 12.83 Bn 416.87 Mn
6 Bio-Techne 11.27 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.11 Bn 8.49 Bn 345.80 Mn
8 Repligen 9.33 Bn 8.31 Bn 110.04 Mn
9 10x Genomics 8.77 Bn 8.21 Bn 112.50 Mn
10 Bruker 8.30 Bn 8.09 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 597.70 Mn
Mar 31, 2026 609.90 Mn
Dec 31, 2025 599.40 Mn
Sep 30, 2025 690.20 Mn
Jun 30, 2025 746.00 Mn
Mar 31, 2025 660.90 Mn
Dec 31, 2024 311.00 Mn
Sep 30, 2024 206.30 Mn
Jun 30, 2024 178.30 Mn
Mar 31, 2024 166.70 Mn
Dec 31, 2023 240.20 Mn
Sep 30, 2023 404.50 Mn
Jun 30, 2023 421.00 Mn
Mar 31, 2023 395.60 Mn
Dec 31, 2022 120.80 Mn
Sep 30, 2022 381.80 Mn
Jun 30, 2022 404.70 Mn
Mar 31, 2022 426.70 Mn
Dec 31, 2021 162.20 Mn
Sep 30, 2021 399.10 Mn